Skip to main content

Articles

Page 2 of 280

  1. Tyrosine kinase inhibitors (TKIs), such as sunitinib, are used for cancer treatment, but may also affect platelet count and function with possible hemostatic consequences. Here, we investigated whether patient...

    Authors: Bibian M. E. Tullemans, Sanne L. N. Brouns, Frauke Swieringa, Siamack Sabrkhany, Franchette W. P. J. van den Berkmortel, Natascha A. J. B. Peters, Peter de Bruijn, Stijn L. W. Koolen, Johan W. M. Heemskerk, Maureen J. B. Aarts and Marijke J. E. Kuijpers
    Citation: BMC Cancer 2022 22:653
  2. Integrative medicine is used frequently alongside chemotherapy treatment in pediatric oncology, but little is known about the influence on toxicity. This German, multi-center, open-label, randomized controlled...

    Authors: Georg Seifert, Sarah B. Blakeslee, Gabriele Calaminus, Farid I. Kandil, Andrea Barth, Toralf Bernig, Carl Friedrich Classen, Selim Corbacioglu, Jürgen Föll, Sven Gottschling, Bernd Gruhn, Claudia vom Hoff-Heise, Holger N. Lode, David Martin, Michaela Nathrath, Felix Neunhoeffer…
    Citation: BMC Cancer 2022 22:652
  3. SURECAN (SUrvivors’ Rehabilitation Evaluation after CANcer) is a multi-phase study developing and evaluating an Acceptance and Commitment Therapy (ACT) intervention integrated with exercise and work when highl...

    Authors: Elisavet Moschopoulou, Debbie Brewin, Damien Ridge, Sheila Donovan, Stephanie J. C. Taylor, Liam Bourke, Gail Eva, Imran Khan and Trudie Chalder
    Citation: BMC Cancer 2022 22:651
  4. Neoadjuvant chemoradiation followed by esophagectomy has been established as the first-line treatment for locally advanced esophageal cancer. Postoperative enteral nutrition has been widely used to improve per...

    Authors: Yuqin Cao, Dingpei Han, Su Yang, Yongmei Shi, Shengguang Zhao, Qianwen Jin, Jian Li, Chengqiang Li, Yajie Zhang, Weiyu Shen, Jinxian He, Mingsong Wang, Guangyu Ji, Zhigang Li, Yi He, Qixun Chen…
    Citation: BMC Cancer 2022 22:650
  5. Prognosis for patients recurred rapidly after resection of pancreatic ductal adenocarcinoma (PDAC) was extremely poor. We proposed the concept of postoperative hyper-progression disease (PO-HPD) to define recu...

    Authors: Siyi Zou, Xinjing Wang, Haoda Chen, Jiewei Lin, Chenlei Wen, Qian Zhan, Hao Chen, Xiongxiong Lu, Xiaxing Deng and Baiyong Shen
    Citation: BMC Cancer 2022 22:649
  6. Cancer survivors are able to live much longer today than in the past due to advances in treatment. The promotion of health behaviors is important to address among cancer survivors. Not only can health behavior...

    Authors: Trevin E. Glasgow, Kandace P. McGuire and Bernard F. Fuemmeler
    Citation: BMC Cancer 2022 22:648
  7. Given the young age of patients with CNS WHO grade 2 and 3 oligodendrogliomas and the relevant risk of neurocognitive, functional, and quality-of-life impairment with the current aggressive standard of care tr...

    Authors: A. Wick, A. Sander, M. Koch, M. Bendszus, S. Combs, T. Haut, A. Dormann, S. Walter, M. Pertz, J. Merkle-Lock, N. Selkrig, R. Limprecht, L. Baumann, M. Kieser, F. Sahm, U. Schlegel…
    Citation: BMC Cancer 2022 22:645
  8. Glioblastoma multiforme (GBM) is one of the most malignant tumors in brain with high morbidity and mortality. Mitophagy plays a significant role in carcinogenesis, metastasis, and invasion. In our study, we ai...

    Authors: Jinghua Wang, Xinqi Qiu, Jiayu Huang, Zewei Zhuo, Hao Chen, Ruijie Zeng, Huihuan Wu, Kehang Guo, Qi Yang, Huiling Ye, Wei Huang and Yujun Luo
    Citation: BMC Cancer 2022 22:644
  9. Hepato-pulmonary metastasis of colorectal cancer (CRC) is a rare disease with poor prognosis. This study aims to establish a highly efficient nomogram model to predict overall survival (OS) and cancer-specific...

    Authors: Shenghe Deng, Zhenxing Jiang, Yinghao Cao, Junnan Gu, Fuwei Mao, Yifan Xue, Le Qin, Ke Liu, Jiliang Wang, Ke Wu and Kailin Cai
    Citation: BMC Cancer 2022 22:643
  10. Glioblastoma (GBM) is the most common primary malignant brain tumor in adults exhibiting infiltration into surrounding tissues, recurrence, and resistance to therapy. GBM infiltration is accomplished by many d...

    Authors: Uchurappa Mala, Tapan Kumar Baral and Kumaravel Somasundaram
    Citation: BMC Cancer 2022 22:642
  11. The systemic inflammatory response resulting from the complex interactions between cancer and the host plays an important role in cancer development. Recently, the lymphocyte-C-reactive protein ratio (LCR), wh...

    Authors: Kozo Miyatani, Shohei Sawata, Masahiro Makinoya, Wataru Miyauchi, Shota Shimizu, Yuji Shishido, Tomoyuki Matsunaga, Manabu Yamamoto, Naruo Tokuyasu, Shuichi Takano, Teruhisa Sakamoto, Toshimichi Hasegawa, Hiroaki Saito and Yoshiyuki Fujiwara
    Citation: BMC Cancer 2022 22:641
  12. Synchronous multiple primary malignant tumors (sMPMTs) are sometimes diagnosed in patients with malignant lymphoma. We herein investigated the prognostic impact of sMPMT in lymphoma patients and the optimal tr...

    Authors: Yu Yagi, Yusuke Kanemasa, Yuki Sasaki, An Ohigashi, Yuka Morita, Taichi Tamura, Shohei Nakamura, Akihiko Kageyama, Yasushi Omuro and Tatsu Shimoyama
    Citation: BMC Cancer 2022 22:640
  13. Malignant pleural mesothelioma, a tumor arising from the membrane covering the lungs and the inner side of the ribs, is a cancer in which genetic alterations of genes encoding proteins that act on or are part ...

    Authors: Loreley Calvet, Odette Dos-Santos, Emmanuel Spanakis, Véronique Jean-Baptiste, Jean-Christophe Le Bail, Armelle Buzy, Pascal Paul, Christophe Henry, Sandrine Valence, Colette Dib, Jack Pollard, Sukhvinder Sidhu, Jürgen Moll, Laurent Debussche and Iris Valtingojer
    Citation: BMC Cancer 2022 22:639
  14. Recurrent esophageal cancer is associated with dismal prognosis. There is no consensus about the role of surgical treatments in patients with limited recurrences. This study aimed to evaluate the role of surgi...

    Authors: Ping-Chung Tsai, Hung-Che Chien, Po-Kuei Hsu, Jung-Jyh Hung, Chien-Sheng Huang, Wen-Hu Hsu and Han-Shui Hsu
    Citation: BMC Cancer 2022 22:637
  15. Aberrant methylation of EphA7 has been reported in the process of carcinogenesis but not in cervical cancer. Therefore, an integration study was performed to explore the association between EphA7 hypermethylat...

    Authors: Wenfan Zhang, Huiling Cao, Jinhao Yang, Jing Zhao, Zheng Liang, Xiaodong Kang and Rong Wang
    Citation: BMC Cancer 2022 22:636
  16. The prognosis of Borrmann type III advanced gastric cancer (AGC) is known to vary significantly among patients. This study aimed to determine which differentially expressed genes (DEGs) are directly related to...

    Authors: Yufei Wang, Tianyi Fang, Yimin Wang, Xin Yin, Lei Zhang, Xinghai Zhang, Daoxu Zhang, Yao Zhang, Xibo Wang, Hao Wang and Yingwei Xue
    Citation: BMC Cancer 2022 22:635
  17. Semaphorins have been found to play important roles in multiple malignancy-related processes. However, the role of Semaphorin 4B (SEMA4B) in lung cancer remains unclear. Here, we aimed to explore the biologica...

    Authors: Jun Jiang, Yuan Lu, Fang Zhang, Tao Pan, Zhipei Zhang, Yi Wan, Xinling Ren and Rui Zhang
    Citation: BMC Cancer 2022 22:632
  18. Non-muscle invasive bladder cancer can be controlled by transurethral resection of bladder (TURB), but suffers from frequent recurrences in 60–70% of cases. Although, recurrence interval after TURB influences ...

    Authors: Seung-hwan Jeong, Jang Hee Han, Chang Wook Jeong, Hyeon Hoe Kim, Cheol Kwak, Hyeong Dong Yuk and Ja Hyeon Ku
    Citation: BMC Cancer 2022 22:631
  19. The phase III clinical study of adjuvant liposomal muramyl tripeptide (MTP-PE) in resected high-grade osteosarcoma (OS) documented positive results that have been translated into regulatory approval, supportin...

    Authors: David J. Barnes, Peter Dutton, Øyvind Bruland, Hans Gelderblom, Ade Faleti, Claudia Bühnemann, Annemiek van Maldegem, Hannah Johnson, Lisa Poulton, Sharon Love, Gesa Tiemeier, Els van Beelen, Karin Herbschleb, Caroline Haddon, Lucinda Billingham, Kevin Bradley…
    Citation: BMC Cancer 2022 22:629
  20. Eukaryotic translation elongation factors 1 δ (EEF1D), has garnered much attention with regards to their role in the drug resistance of cancers. In this paper, we investigated the effects and mechanisms of inc...

    Authors: Qia Xu, Yun Liu, Shenyi Wang, Jing Wang, Liwei Liu, Yin Xu and Yide Qin
    Citation: BMC Cancer 2022 22:628
  21. Triple-negative breast cancer (TNBC) constitutes 10–20% of breast cancers and is challenging to treat due to a lack of effective targeted therapies. Previous studies in TNBC cell lines showed in vitro growth i...

    Authors: Nanda Kumar Yellapu, Thuc Ly, Mihaela E. Sardiu, Dong Pei, Danny R. Welch, Jeffery A. Thompson and Devin C. Koestler
    Citation: BMC Cancer 2022 22:627
  22. Epidermal growth factor receptor (EGFR) activation is associated with increased production of interleukin 6 (IL6), which is intensified by radiotherapy (RT) induced inflammatory response. Elevated IL6 levels i...

    Authors: Lucas Maahs, Ahmed I. Ghanem, Radhika Gutta, Amy Tang, Swarn Arya, Zaid Al Saheli, Haythem Ali, Steven Chang, Samantha Tam, Vivian Wu, Farzan Siddiqui and Jawad Sheqwara
    Citation: BMC Cancer 2022 22:626
  23. Tropomyosin receptor kinase (TRK) fusion proteins resulting from neurotrophic tyrosine receptor kinase (NTRK) gene fusions are rare primary oncogenic drivers in a wide array of tumors. Larotrectinib is a first-in...

    Authors: James C. H. Yang, Marcia S. Brose, Gilberto Castro, Edward S. Kim, Ulrik N. Lassen, Serge Leyvraz, Alberto Pappo, Fernando López-Ríos, John A. Reeves, Marc Fellous, Frédérique Penault-Llorca, Erin R. Rudzinski, Ghazaleh Tabatabai, Gilles Vassal, Alexander Drilon and Jonathan Trent
    Citation: BMC Cancer 2022 22:625
  24. Current guidelines consider T-DM1 the standard 2nd line therapy for HER2 positive metastatic breast cancer (MBC) patients following trastuzumab (T) + pertuzumab (P) and taxane 1st line treatment. Despite this, th...

    Authors: Claudia Omarini, Federico Piacentini, Isabella Sperduti, Krisida Cerma, Monica Barbolini, Fabio Canino, Cecilia Nasso, Christel Isca, Federica Caggia, Massimo Dominici and Luca Moscetti
    Citation: BMC Cancer 2022 22:623
  25. Polyploid giant cancer cells (PGCCs) have been observed in epithelial ovarian tumors. They can resist antimitotic drugs, thus participating in tumor maintenance and recurrence. Although their origin remains un...

    Authors: Lucile Yart, Daniel Bastida-Ruiz, Mathilde Allard, Pierre-Yves Dietrich, Patrick Petignat and Marie Cohen
    Citation: BMC Cancer 2022 22:622
  26. Treatment of cancer patients in certified cancer centers, that meet specific quality standards in term of structures and procedures of medical care, is a national treatment goal in Germany. However, convincing...

    Authors: Martin Roessler, Jochen Schmitt, Christoph Bobeth, Michael Gerken, Kees Kleihues-van Tol, Christoph Reissfelder, Bettina M. Rau, Marius Distler, Pompiliu Piso, Christian Günster, Monika Klinkhammer-Schalke, Olaf Schoffer and Veronika Bierbaum
    Citation: BMC Cancer 2022 22:621
  27. Cholangiocarcinoma (CHOL) is a malignant tumor that originates in the extrahepatic bile duct and can extend from the hilar region to the lower end of the common bile duct. The prognosis of CHOL patients is par...

    Authors: Huaqiang Zhu, Haini Zhao, Jianlu Wang, Shuchao Zhao, Chaoqun Ma, Dongliang Wang, Hengjun Gao, Faji Yang, Qingqiang Ni, Hongguang Li, Xu Zhou, Chunqing Zhang and Jun Lu
    Citation: BMC Cancer 2022 22:620
  28. An imbalance of intracellular iron metabolism can lead to the occurrence of ferroptosis. Ferroptosis can be a factor in the remodeling of the immune microenvironment and can affect the efficacy of cancer immun...

    Authors: Xiao-Fen Li, Wen-Fen Fu, Jie Zhang and Chuan-Gui Song
    Citation: BMC Cancer 2022 22:619
  29. Breast cancer and lung cancer are the top two malignancies in the female population and the number of patients with breast cancer and subsequent primary lung cancer has increased significantly in recent years....

    Authors: Yan Wang, Wenpeng Song, Sicheng Zhou, Shuai Chang, Junke Chang, Jie Tian, Liming Zhang, Jue Li and Guowei Che
    Citation: BMC Cancer 2022 22:618
  30. The CheckMate 025 trial established nivolumab monotherapy as one of the standards of care in previously treated advanced or metastatic renal cell carcinoma (aRCC). However, supporting real-world data is lackin...

    Authors: T. Waddell, K. Fife, R. Griffiths, A. Sharma, P. Dhokia, L. Groves, M. Hurst, C. Tsang, D. Sugrue, S. McKenna, J. Houghton and R. Carroll
    Citation: BMC Cancer 2022 22:617
  31. Cisplatin-based concurrent chemoradiotherapy has been identified as the primary and standard treatment for locally advanced nasopharyngeal carcinoma (NPC). However, the side effects of cisplatin affect the com...

    Authors: Zhiru Li, Chao Li, Dong Yang, Junmei Song, Ting Liu, Ziyan Zhou, Lifang Zhou and Min Kang
    Citation: BMC Cancer 2022 22:616
  32. To investigate the feasibility, safety, and clinical application value of single photon emission computed tomography/computed tomography (SPECT/CT)-guided bone marrow biopsy (BMB) in breast cancer (BC) patient...

    Authors: Xiaomin Li, Caixia An and Wanchun Zhang
    Citation: BMC Cancer 2022 22:614
  33. A malignancy of the liver, hepatocellular carcinoma (HCC) is among the most common and second-leading causes of cancer-related deaths worldwide. A reliable prognosis model for guidance in choosing HCC therapie...

    Authors: Chunting Zeng, Linmeng Zhang, Chanhua Luo, Chen Yang, Xiaowen Huang, Linfeng Fan, Jiarong Li, Fengsheng Chen and Zelong Luo
    Citation: BMC Cancer 2022 22:613
  34. Glioblastoma (GBM) has a high incidence rate, invasive growth, and easy recurrence, and the current therapeutic effect is less than satisfying. Pyroptosis plays an important role in morbidity and progress of G...

    Authors: Min-Rui Ding, Yan-Jie Qu, Xiao Peng, Jin-Fang Chen, Meng-Xue Zhang, Tong Zhang, Bing Hu and Hong-Mei An
    Citation: BMC Cancer 2022 22:611
  35. The management of melanoma patients with metastatic melanoma in the sentinel nodes (SN) is evolving based on the results of trials questioning the impact of completion lymph node dissection (CLND) and demonstr...

    Authors: Saveria Tropea, Paolo Del Fiore, Andrea Maurichi, Roberto Patuzzo, Mario Santinami, Simone Ribero, Pietro Quaglino, Virginia Caliendo, Lorenzo Borgognoni, Serena Sestini, Giuseppe Giudice, Eleonora Nacchiero, Corrado Caracò, Adriana Cordova, Nicola Solari, Dario Piazzalunga…
    Citation: BMC Cancer 2022 22:610
  36. Although pancreatic ductal adenocarcinoma (PDAC) rarely metastasizes to the skeleton, disseminated tumor cells have been detected in bone marrow samples from patients with this disease. The prognostic value of...

    Authors: Oddmund Nordgård, Morten Lapin, Kjersti Tjensvoll, Satu Oltedal, Karin Hestnes Edland, Nicolay Bore Neverdahl, Dmitrij Fostenes, Herish Garresori, Nils Glenjen, Rune Smaaland and Bjørnar Gilje
    Citation: BMC Cancer 2022 22:609
  37. The multidisciplinary treatment including induction chemotherapy plus conversion surgery (CS) has attracted attention as a new strategy to improve the outcome of metastatic gastric cancer (MGC). However, it is...

    Authors: Jun Kinoshita, Sachio Fushida, Takahisa Yamaguchi, Hideki Moriyama, Hiroto Saito, Mari Shimada, Shiro Terai, Koichi Okamoto, Keishi Nakamura, Itasu Ninomiya, Shintaro Yagi and Noriyuki Inaki
    Citation: BMC Cancer 2022 22:608
  38. Anal cancer is primarily treated using concurrent chemoradiotherapy (CRT), with conformal techniques such as intensity modulated radiotherapy (IMRT) and volumetric arc therapy (VMAT) now being the standard tec...

    Authors: Stelios Theophanous, Robert Samuel, John Lilley, Ann Henry, David Sebag-Montefiore, Alexandra Gilbert and Ane L. Appelt
    Citation: BMC Cancer 2022 22:607
  39. Hypomethylation of long interspersed nuclear element 1 (LINE-1) is characteristic of various cancer types, including colorectal cancer (CRC). Malfunction of several factors or alteration of methyl-donor molecu...

    Authors: Krisztina A. Szigeti, Alexandra Kalmár, Orsolya Galamb, Gábor Valcz, Barbara K. Barták, Zsófia B. Nagy, Sára Zsigrai, Ildikó Felletár, Árpád V. Patai, Tamás Micsik, Márton Papp, Eszter Márkus, Zsolt Tulassay, Peter Igaz, István Takács and Béla Molnár
    Citation: BMC Cancer 2022 22:605
  40. Real-world data (RWD) is increasingly being embraced as an invaluable source of information to address clinical and policy-relevant questions that are unlikely to ever be answered by clinical trials. However, ...

    Authors: Lucy Gately, Katharine Drummond, Mark Rosenthal, Rosemary Harrup, Anthony Dowling, Andrew Gogos, Zarnie Lwin, Ian Collins, David Campbell, Elizabeth Ahern, Claire Phillips, Hui K. Gan, Iwan Bennett, Oliver M. Sieber and Peter Gibbs
    Citation: BMC Cancer 2022 22:604
  41. This study aims to evaluate the incidence of and identify risk factors for gastrointestinal (GI) and genitourinary (GU) fistula or perforation formation with or without bevacizumab in patients with recurrent c...

    Authors: Woo Yeon Hwang, Suk-Joon Chang, Hee Seung Kim, Nam Kyeong Kim, Tae Hun Kim, Yeorae Kim, Tae Wook Kong, Eun Ji Lee, Soo Jin Park, Seung Hyuk Shim, Joo-Hyuk Son, Dong Hoon Suh and Eun Jung Yang
    Citation: BMC Cancer 2022 22:603
  42. There are different subsets of T regulatory cells (Tregs), orchestrating critical roles in the regulation of anti-tumor immunity in colorectal cancer (CRC). In this study, we report that a high frequency of ci...

    Authors: Mohammad A. Al-Mterin, Khaled Murshed, Alhasan Alsalman, Ala Abu-Dayeh and Eyad Elkord
    Citation: BMC Cancer 2022 22:601

Featured videos

View featured videos from across the BMC-series journals